UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)


☒						QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December ~~31, 2022~~30, 2023


☐						TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______ to ______

Commission File Number 001-14423

PLEXUS CORP.

(Exact name of registrant as specified in charter)


Wisconsin						39-1344447
(State or other jurisdiction of incorporation)						(I.R.S. Employer Identification No.)

One Plexus Way

Neenah, Wisconsin 54957

(Address of principal executive offices) (Zip Code)

Telephone Number (920) 969-6000

(Registrant’s telephone number, including Area Code)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol	Name of each exchange on which registered
Common Stock, $0.01 par value	PLXS	The Nasdaq Global Select Market

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

☐

Non-accelerated filer

☐

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of January ~~31, 2023,~~30, 2024, there were ~~27,702,483~~27,611,672 shares of common stock outstanding.

Table of Contents

PLEXUS CORP.

TABLE OF CONTENTS

December ~~31, 2022~~30, 2023



PART I. I . FINANCIAL INFORMATION			3
ITEM 1. FINANCIAL STATEMENTS			3
Condensed Consolidated Statements of Comprehensive Income			3
Condensed Consolidated Balance Sheet			4
Condensed Consolidated Statements of Shareholders' Equity			5
Condensed Consolidated Statements of Cash Flows			6
Notes to Condensed Consolidated Financial Statements			7
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS			18
"Safe Harbor" Cautionary Statement Under the Private Securities Litigation Reform Act of 1995			18
Overview			19
Results of ~~Oper~~a ~~tions~~Operations			2019
Liquidity of Capital Resources			23
Disclosure About Critical Accounting Policies			2726
New Ac ~~counting~~Accounting Pronouncements			2726
ITEM 3 .3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK			2726
ITEM 4. CONTROLS AND PROCEDURES			2827
ITEM 5. OTHER INFORMATION			27
PART I I. II. OTHER INFORMATION			2827
ITEM 1A. Risk Factors			28
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceed			28
ITEM 6 .6. Exhibits			2928
SIGNATURES			3029

Table of Contents

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

PLEXUS CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(in thousands, except per share data)

Unaudited


			Three Months Ended
			December 31, 2022		January 1, 2022
		Three Months Ended						Three Months Ended
		December 30, 2023					December 30, 2023		December 31, 2022
Net sales	Net sales		$	1,093,925	$	817,456
Cost of sales	Cost of sales		992,726		747,460
Gross profit	Gross profit		101,199		69,996
Selling and administrative expenses	Selling and administrative expenses		43,858		37,502
Restructuring and impairment charges			—		2,021
Operating income	Operating income		57,341		30,473
Other income (expense):	Other income (expense):
Interest expense
Interest expense
Interest expense	Interest expense		(6,894)		(3,046)
Interest income	Interest income		934		271
Miscellaneous, net	Miscellaneous, net		(1,944)		(923)
Income before income taxes	Income before income taxes		49,437		26,775
Income tax expense	Income tax expense		7,247		3,352
Net income	Net income		$	42,190	$	23,423
Earnings per share:	Earnings per share:
Basic	Basic		$	1.53	$	0.84
Basic
Basic
Diluted	Diluted		$	1.49	$	0.82
Weighted average shares outstanding:	Weighted average shares outstanding:
Basic
Basic
Basic	Basic		27,639		28,018
Diluted	Diluted		28,305		28,709
Comprehensive income:	Comprehensive income:
Net income	Net income		$	42,190	$	23,423
Other comprehensive income (loss):
Net income
Net income
Other comprehensive income:
Derivative instrument and other fair value adjustments
Derivative instrument and other fair value adjustments
Derivative instrument and other fair value adjustments	Derivative instrument and other fair value adjustments		8,439		1,272
Foreign currency translation adjustments	Foreign currency translation adjustments		13,777		(1,578)
Other comprehensive income (loss)			22,216		(306)
Other comprehensive income
Total comprehensive income	Total comprehensive income		$	64,406	$	23,117

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

PLEXUS CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except per share data)

Unaudited

December 31, 2022 October 1, 2022
ASSETS
Current assets:
Cash and cash equivalents $ 247,880 $ 274,805
Restricted cash 31 665
Accounts receivable, net of allowances of $2,531 and $1,961, respectively 733,962 737,696
Contract assets 119,016 138,540
Inventories, net 1,645,011 1,602,783
Prepaid expenses and other 68,401 61,633
Total current assets 2,814,301 2,816,122
Property, plant and equipment, net 448,325 444,705
Operating lease right-of-use assets 64,069 65,134
Deferred income taxes 39,337 39,075
Other assets 29,260 28,189
Total non-current assets 580,991 577,103
Total assets $ 3,395,292 $ 3,393,225
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Current portion of long-term debt and finance lease obligations $ 329,076 $ 273,971
Accounts payable 753,755 805,583
Customer deposits 511,037 480,486
Accrued salaries and wages 64,126 88,876
Other accrued liabilities 296,466 357,273
Total current liabilities 1,954,460 2,006,189
Long-term debt and finance lease obligations, net of current portion 187,272 187,776
Long-term accrued income taxes payable 42,019 42,019
Long-term operating lease liabilities 32,149 33,628
Deferred income taxes payable 5,616 6,327
Other liabilities 23,517 21,555
Total non-current liabilities 290,573 291,305
Total liabilities 2,245,033 2,297,494
Commitments and contingencies
Shareholders’ equity:
Preferred stock, $0.01 par value, 5,000 shares authorized, none issued or outstanding — —
Common stock, $0.01 par value, 200,000 shares authorized, 54,133 and 54,084 shares issued, respectively, and 27,612 and 27,679 shares outstanding, respectively 541 541
Additional paid-in capital 654,059 652,467
Common stock held in treasury, at cost, 26,521 and 26,405 shares, respectively (1,104,953) (1,093,483)
Retained earnings 1,614,424 1,572,234
Accumulated other comprehensive loss (13,812) (36,028)
Total shareholders’ equity 1,150,259 1,095,731
Total liabilities and shareholders’ equity $ 3,395,292 $ 3,393,225


	December 30, 2023		September 30, 2023
ASSETS
Current assets:
Cash and cash equivalents	$	231,982	$	256,233
Restricted cash	430		421
Accounts receivable, net of allowances of $1,808 and $1,914, respectively	656,207		661,542
Contract assets	131,640		142,297
Inventories	1,575,094		1,562,037
Prepaid expenses and other	54,879		49,693
Total current assets	2,650,232		2,672,223
Property, plant and equipment, net	498,979		492,036
Operating lease right-of-use assets	67,420		69,363
Deferred income taxes	62,721		62,590
Other assets	25,261		24,960
Total non-current assets	654,381		648,949
Total assets	$	3,304,613	$	3,321,172

LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Current portion of long-term debt and finance lease obligations	$	251,119	$	240,205
Accounts payable	647,386		646,610
Advanced payments from customers	709,709		760,351
Accrued salaries and wages	74,828		94,099
Other accrued liabilities	60,520		71,402
Total current liabilities	1,743,562		1,812,667
Long-term debt and finance lease obligations, net of current portion	192,118		190,853
Accrued income taxes payable	31,382		31,382
Long-term operating lease liabilities	35,989		38,552
Deferred income taxes	4,410		4,350
Other liabilities	30,397		28,986
Total non-current liabilities	294,296		294,123
Total liabilities	2,037,858		2,106,790
Commitments and contingencies
Shareholders’ equity:
Preferred stock, $0.01 par value, 5,000 shares authorized, none issued or outstanding	—		—
Common stock, $0.01 par value, 200,000 shares authorized, 54,335 and 54,297 shares issued, respectively, and 27,504 and 27,466 shares outstanding, respectively	543		543
Additional paid-in capital	663,542		661,270
Common stock held in treasury, at cost, 26,831 and 26,831 shares, respectively	(1,134,429)		(1,134,429)
Retained earnings	1,740,543		1,711,328
Accumulated other comprehensive loss	(3,444)		(24,330)
Total shareholders’ equity	1,266,755		1,214,382
Total liabilities and shareholders’ equity	$	3,304,613	$	3,321,172

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

PLEXUS CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(in thousands)

Unaudited

Three Months Ended
December 31, 2022 January 1, 2022
Common stock - shares outstanding
Beginning of period 27,679 28,047
Exercise of stock options and vesting of other share-based awards 49 60
Treasury shares purchased (116) (110)
End of period 27,612 27,997
Total stockholders' equity, beginning of period $ 1,095,731 $ 1,028,232
Common stock - par value
Beginning of period 541 538
Exercise of stock options and vesting of other share-based awards — 1
End of period 541 539
Additional paid-in capital
Beginning of period 652,467 639,778
Share-based compensation expense 5,683 6,270
Exercise of stock options and vesting of other share-based awards, including tax withholding (4,091) (3,394)
End of period 654,059 642,654
Treasury stock
Beginning of period (1,093,483) (1,043,091)
Treasury shares purchased (11,470) (10,131)
End of period (1,104,953) (1,053,222)
Retained earnings
Beginning of period 1,572,234 1,433,991
Net income 42,190 23,423
End of period 1,614,424 1,457,414
Accumulated other comprehensive loss
Beginning of period (36,028) (2,984)
Other comprehensive income (loss) 22,216 (306)
End of period (13,812) (3,290)
Total stockholders' equity, end of period $ 1,150,259 $ 1,044,095


	Three Months Ended
	December 30, 2023		December 31, 2022
Common stock - shares outstanding
Beginning of period	27,466		27,679
Exercise of stock options and vesting of other share-based awards	38		49
Treasury shares purchased	—		(116)
End of period	27,504		27,612

Total stockholders' equity, beginning of period	$	1,214,382	$	1,095,731
Common stock - par value
Beginning of period	543		541
Exercise of stock options and vesting of other share-based awards	—		—
End of period	543		541
Additional paid-in capital
Beginning of period	661,270		652,467
Share-based compensation expense	5,178		5,683
Exercise of stock options and vesting of other share-based awards, including tax withholding	(2,906)		(4,091)
End of period	663,542		654,059
Treasury stock
Beginning of period	(1,134,429)		(1,093,483)
Treasury shares purchased	—		(11,470)
End of period	(1,134,429)		(1,104,953)
Retained earnings
Beginning of period	1,711,328		1,572,234
Net income	29,215		42,190
End of period	1,740,543		1,614,424
Accumulated other comprehensive loss
Beginning of period	(24,330)		(36,028)
Other comprehensive income	20,886		22,216
End of period	(3,444)		(13,812)
Total stockholders' equity, end of period	$	1,266,755	$	1,150,259

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

PLEXUS CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

Unaudited


			Three Months Ended
			December 31, 2022		January 1, 2022
		Three Months Ended						Three Months Ended
		December 30, 2023					December 30, 2023		December 31, 2022
Cash flows from operating activities	Cash flows from operating activities
Net income	Net income		$	42,190	$	23,423
Net income
Net income
Adjustments to reconcile net income to net cash flows from operating activities:	Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization
Depreciation and amortization
Depreciation and amortization	Depreciation and amortization		16,290		15,489
Share-based compensation expense and related charges	Share-based compensation expense and related charges		5,683		6,357
Other, net	Other, net		502		602
Changes in operating assets and liabilities, excluding impacts of currency:	Changes in operating assets and liabilities, excluding impacts of currency:
Accounts receivable
Accounts receivable
Accounts receivable	Accounts receivable		10,506		(70,159)
Contract assets	Contract assets		19,745		9,904
Inventories	Inventories		(31,409)		(214,416)
Other current and non-current assets	Other current and non-current assets		(7,270)		(9,436)
Accrued income taxes payable	Accrued income taxes payable		(2,655)		1,121
Accounts payable	Accounts payable		(52,702)		76,222
Customer deposits			27,170		60,743
Advanced payments from customers
Other current and non-current liabilities	Other current and non-current liabilities		(76,844)		11,171
Cash flows used in operating activities	Cash flows used in operating activities		(48,794)		(88,979)
Cash flows from investing activities	Cash flows from investing activities
Payments for property, plant and equipment	Payments for property, plant and equipment		(23,085)		(33,246)
Payments for property, plant and equipment
Payments for property, plant and equipment
Other, net	Other, net		1,503		(124)
Cash flows used in investing activities	Cash flows used in investing activities		(21,582)		(33,370)
Cash flows from financing activities	Cash flows from financing activities
Borrowings under debt agreements
Borrowings under debt agreements
Borrowings under debt agreements	Borrowings under debt agreements		197,000		181,134
Payments on debt and finance lease obligations	Payments on debt and finance lease obligations		(142,001)		(97,565)
Repurchases of common stock	Repurchases of common stock		(11,470)		(10,131)
Proceeds from exercise of stock options	Proceeds from exercise of stock options		—		307
Payments related to tax withholding for share-based compensation	Payments related to tax withholding for share-based compensation		(4,091)		(3,702)
Cash flows provided by financing activities	Cash flows provided by financing activities		39,438		70,043
Effect of exchange rate changes on cash and cash equivalents	Effect of exchange rate changes on cash and cash equivalents		3,379		184
Net decrease in cash and cash equivalents and restricted cash	Net decrease in cash and cash equivalents and restricted cash		(27,559)		(52,122)
Cash and cash equivalents and restricted cash:	Cash and cash equivalents and restricted cash:
Beginning of period	Beginning of period		275,470		270,513
Beginning of period
Beginning of period
End of period	End of period		$	247,911	$	218,391

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

PLEXUS CORP. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED DECEMBER ~~31, 2022~~30, 2023 AND ~~JANUARY 1,~~DECEMBER 31, 2022

Unaudited

1.Basis of Presentation

Basis of Presentation:

The accompanying Condensed Consolidated Financial Statements included herein have been prepared by Plexus Corp. and its subsidiaries (together “Plexus” or the “Company”) without audit and pursuant to the rules and regulations of the United States (“U.S.”) Securities and Exchange Commission (“SEC”). The accompanying Condensed Consolidated Financial Statements reflect all adjustments, which include normal recurring adjustments necessary for the fair statement of the condensed consolidated financial position of the Company as of December ~~31, 2022~~30, 2023 and ~~October 1, 2022,~~September 30, 2023, the results of operations and shareholders' equity for the three months ended December ~~31, 2022~~30, 2023 and ~~January 1,~~December 31, 2022, and the cash flows for the same three month periods.

The Company’s fiscal year ends on the Saturday closest to September 30. The Company uses a “4-4-5” weekly accounting system for the interim periods in each quarter. Each quarter, therefore, ends on a Saturday at the end of the 4-4-5 period. Periodically, an additional week must be added to the fiscal year to re-align with the Saturday closest to September 30. All fiscal quarters presented herein included 13 weeks.

Certain information and footnote disclosures, normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP"), have been condensed or omitted pursuant to the SEC’s rules and regulations dealing with interim financial statements. However, the Company believes that the disclosures made in the Condensed Consolidated Financial Statements included herein are adequate to make the information presented not misleading. It is suggested that these Condensed Consolidated Financial Statements be read in conjunction with the Consolidated Financial Statements and notes thereto included in the Company’s ~~2022~~2023 Annual Report on Form 10-K.

The preparation of financial statements requires management to make estimates and assumptions that affect the amounts reported in the Condensed Consolidated Financial Statements and notes thereto. The Company has considered information available as of the date of issuance of these financial statements and, other than the information disclosed in Note 15, "Subsequent Events", is not aware of any specific events or circumstances that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities. These estimates may change as new events occur and additional information becomes available. Actual results could differ materially from these estimates.

Reclassification:

Certain prior year amounts in the consolidated financial statements and notes thereto have been reclassified related to advanced payments from customers to conform to the current year's presentation.

Recently ~~Issued~~Adopted Accounting ~~Pronouncements Not Yet Adopted:~~Pronouncements:

In September 2022, the FASB issued ASU 2022-04, which requires enhanced disclosures about supplier finance programs. The Company adopted this guidance during the first quarter of fiscal 2024 with no material impact to the Company's Consolidated Financial Statements; however, the impact of the new standard on future periods will depend on the facts and circumstances of future transactions.

Recently Issued Accounting Pronouncements Not Yet Adopted:

In November 2023, the FASB issued ASU 2023-07, which requires enhanced disclosures for segment reporting. The guidance is effective for the Company beginning in the first quarter of fiscal ~~2024.~~2025. We are currently evaluating the impact that the updated standard will have on our financial statement disclosures.

In December 2023, the FASB issued ASU 2023-09, which requires enhanced disclosures for income taxes. The guidance is effective for the Company beginning in the first quarter of fiscal 2026. Early adoption is permitted. ~~The Company is~~We are currently inevaluating the ~~process of assessing~~impact that the ~~impacts of the guidance.~~updated standard will have on our financial statement disclosures.

The Company does not believe that any other recently issued accounting standards will have a material impact on its Consolidated Financial Statements or apply to its operations.

Table of Contents

2. Inventories

Inventories as of December ~~31, 2022~~30, 2023 and ~~October 1, 2022~~September 30, 2023 consisted of the following (in thousands):


			December 31, 2022		October 1, 2022
		December 30, 2023					December 30, 2023	September 30, 2023
Raw materials	Raw materials		$	1,468,942	$	1,433,353
Work-in-process	Work-in-process		81,822		81,207
Finished goods	Finished goods		94,247		88,223
Total inventories, net			$	1,645,011	$	1,602,783
Total inventories

In certain circumstances, per contractual terms, customer deposits are received by the Company to offset inventory risks. The total amount of customer deposits related to inventory and included within ~~current liabilities~~advanced payments from customers on the accompanying Condensed

~~Table of Contents~~

Consolidated Balance Sheets as of December ~~31, 2022~~30, 2023 and ~~October 1, 2022~~September 30, 2023 was ~~$483.1~~$541.3 million and ~~$463.2~~$590.2 million, respectively.

3. Debt, Finance Lease and Other Financing Obligations

Debt and finance lease ~~and other financing~~ obligations as of December ~~31, 2022~~30, 2023 and ~~October 1, 2022~~September 30, 2023 consisted of the following (in thousands):


			December 31, 2022		October 1, 2022
		December 30, 2023					December 30, 2023	September 30, 2023
4.05% Senior Notes, due June 15, 2025	4.05% Senior Notes, due June 15, 2025		$	100,000	$	100,000
4.22% Senior Notes, due June 15, 2028	4.22% Senior Notes, due June 15, 2028		50,000		50,000
Borrowings under Credit Facility			320,000		263,000
Borrowings under the Credit Facility
Finance lease and other financing obligations	Finance lease and other financing obligations		47,786		50,269
Unamortized deferred financing fees	Unamortized deferred financing fees		(1,438)		(1,522)
Total obligations	Total obligations		516,348		461,747
Less: current portion	Less: current portion		(329,076)		(273,971)
Long-term debt, finance lease and other financing obligations, net of current portion	Long-term debt, finance lease and other financing obligations, net of current portion		$	187,272	$	187,776

As of December ~~31, 2022,~~30, 2023, the Company was in compliance with covenants for all debt agreements.

During the three months ended December ~~31, 2022,~~30, 2023, the highest daily borrowing under the Company's 5-year senior unsecured revolving credit facility (referred to as the "Credit Facility") was ~~$394.0~~$343.0 million; the average daily borrowings were ~~$320.9~~$284.1 million.

The fair value of the Company’s debt, excluding finance lease and other financing obligations, ~~was~~ wa~~$461.5~~s $388.2 million and $~~401.6~~374.3 million as of December ~~31, 2022~~30, 2023 and ~~October 1, 2022,~~September 30, 2023, respectively. The carrying value of the Company's debt, excluding finance lease and other financing obligations, was $~~470.0~~393.0 million and $~~413.0~~383.0 million as of December ~~31, 2022~~30, 2023 and ~~October 1, 2022,~~September 30, 2023, respectively. If measured at fair value in the financial statements, the Company's debt would be classified as Level 2 in the fair value hierarchy. Refer to Note 4, "Derivatives and Fair Value Measurements," for further information regarding the Company's fair value calculations and classifications.

4. Derivatives and Fair Value Measurements

All derivatives are recognized in the accompanying Condensed Consolidated Balance Sheets at their estimated fair value. The Company uses derivatives to manage the variability of foreign currency obligations. The Company has cash flow hedges related to forecasted foreign currency obligations, in addition to non-designated hedges to manage foreign currency exposures associated with certain foreign currency denominated assets and liabilities. The Company does not enter into derivatives for speculative purposes.

Table of Contents

The Company designates some foreign currency exchange contracts as cash flow hedges of forecasted foreign currency expenses. Changes in the fair value of the derivatives that qualify as cash flow hedges are recorded in "Accumulated other comprehensive loss" in the accompanying Condensed Consolidated Balance Sheets until earnings are affected by the variability of the cash flows. In the next twelve months, the Company estimates that ~~$2.4~~$3.4 million of unrealized gains, net of tax, related to cash flow hedges will be reclassified from other comprehensive income ~~(loss)~~ into earnings. Changes in the fair value of the non-designated derivatives related to recognized foreign currency denominated assets and liabilities are recorded in "Miscellaneous, net" in the accompanying Condensed Consolidated Statements of Comprehensive Income.

The Company enters into forward currency exchange contracts for its operations in certain jurisdictions in the AMER and APAC segments on a rolling basis. The Company had cash flow hedges outstanding with a notional value of ~~$148.7~~$200.6 million as of December ~~31, 2022,~~30, 2023, and a notional value of ~~$143.2~~$215.4 million as of ~~October 1, 2022.~~September 30, 2023. These forward currency contracts fix the exchange rates for the settlement of future foreign currency obligations that have yet to be realized. The total fair value of the forward currency exchange contracts was a ~~$2.4~~$3.4 million asset as of December ~~31, 2022,~~30, 2023 and a ~~$6.0~~$5.0 million liability as of ~~October 1, 2022.~~

~~Table of Contents~~

September 30, 2023.

The Company had additional forward currency exchange contracts outstanding as of December ~~31, 2022,~~30, 2023, with a notional value of ~~$113.5~~$175.8 million; there were ~~$60.1~~$145.5 million of such contracts outstanding as of ~~October 1, 2022.~~September 30, 2023. The Company did not designate these derivative instruments as hedging instruments. The net settlement amount (fair value) related to these contracts is recorded on the Condensed Consolidated Balance Sheets as either a current or long-term asset or liability, depending on the term, and as an element of "Miscellaneous, net" in the Condensed Consolidated Statements of Comprehensive Income. The total fair value of these derivatives was a ~~$1.0~~$3.0 million asset as of December ~~31, 2022,~~30, 2023 and a ~~$0.3~~$1.3 million ~~asset~~liability as of ~~October 1, 2022.~~September 30, 2023.

The tables below present information regarding the fair values of derivative instruments ~~(as defined in Note 1, "Description of Business and Significant Accounting Policies")~~ and the effects of derivative instruments on the Company’s Condensed Consolidated Financial Statements:

Fair Values of Derivative Instruments (in thousands)

Derivative Assets

Derivative Liabilities

Derivative Assets

Derivative Liabilities

December 31,
2022

October 1,
2022

December 31,
2022

October 1,
2022

December 30,
2023

September 30,
2023

December 30,
2023

September 30,
2023

Derivatives designated as hedging instruments

Balance sheet
classification

Fair Value

Balance sheet
classification

Fair Value

Derivatives designated as hedging instruments

Balance sheet
classification

Fair Value

Balance sheet
classification

Fair Value

Foreign currency forward contracts

Prepaid expenses and other

2,451

715

Other accrued liabilities

6,747

Fair Values of Derivative Instruments (in thousands)

Derivative Assets

Derivative Liabilities

Derivative Assets

Derivative Liabilities

December 31,
2022

October 1,
2022

December 31,
2022

October 1,
2022

December 30,
2023

September 30,
2023

December 30,
2023

September 30,
2023

Derivatives not designated as hedging instruments

Balance sheet
classification

Fair Value

Balance sheet
classification

Fair Value

Derivatives not designated as hedging instruments

Balance sheet
classification

Fair Value

Balance sheet
classification

Fair Value

Foreign currency forward contracts

Prepaid expenses and other

2,487

1,555

Other accrued liabilities

1,486

1,249

The Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Loss ("OCL") (in thousands)

for the Three Months Ended

Derivatives in cash flow hedging relationships

Amount of Gain Recognized in OCL on Derivatives

Derivatives in cash flow hedging relationships

Amount of Gain Recognized in OCL on Derivatives

December 31, 2022

January 1, 2022

December 30, 2023

December 31, 2022

Foreign currency forward contracts

6,150

470

Derivative Impact on Loss Recognized in Condensed Consolidated Statements of Comprehensive Income (in thousands)
for the Three Months Ended
Derivatives in cash flow hedging relationships Classification of Loss Reclassified from Accumulated OCL into Income Amount of Loss Reclassified from Accumulated OCL into Income
December 31, 2022 January 1, 2022
Foreign currency forward contracts Cost of sales $ (2,132) $ (743)
Foreign currency forward contracts Selling and administrative expenses $ (157) $ (59)

Table of Contents

Derivatives not designated as hedging instruments Location of Gain (Loss) Recognized on Derivatives in Income Amount of Gain (Loss) on Derivatives Recognized in Income
December 31, 2022 January 1, 2022
Foreign currency forward contracts Miscellaneous, net $ 747 $ (43)

Derivative Impact on Gain (Loss) Recognized in Condensed Consolidated Statements of Comprehensive Income (in thousands)

for the Three Months Ended

Derivatives in cash flow hedging relationships

Classification of Loss Reclassified from Accumulated OCL into Income

Amount of Loss Reclassified from Accumulated OCL into Income

December 30, 2023

December 31, 2022

Foreign currency forward contracts

Cost of sales

(2,789)

(2,132)

Foreign currency forward contracts

Selling and administrative expenses

(162)

(157)

Derivatives not designated as hedging instruments

Location of Gain Recognized on Derivatives in Income

Amount of Gain on Derivatives Recognized in Income

December 30, 2023

December 31, 2022

Foreign currency forward contracts

Miscellaneous, net

2,340

747

Fair Value Measurements:

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (or exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses quoted market prices when available or discounted cash flows to calculate

~~Table of Contents~~

fair value. The accounting guidance establishes a fair value hierarchy based on three levels of inputs that may be used to measure fair value. The input levels are:

Level 1: Quoted (observable) market prices in active markets for identical assets or liabilities.

Level 2: Inputs other than Level 1 that are observable, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability.

Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the asset or liability.

The following table lists the fair values of ~~assets of~~ the Company’s derivatives as of December ~~31, 2022~~30, 2023 and ~~October 1, 2022,~~September 30, 2023 by input level:

Fair Value Measurements Using Input Levels Asset/(Liability) (in thousands)

Fiscal period ended December 31, 2022

Level 1

Level 2

Level 3

Total

Fair Value Measurements Using Input Levels Asset / (Liability) (in thousands)

Fiscal period ended December 30, 2023

Level 1

Level 2

Level 3

Total

Derivatives

Foreign currency forward contracts

—

3,408

—

3,408

Fiscal period ended October 1, 2022

Fiscal period ended September 30, 2023

Derivatives

Foreign currency forward contracts

—

(5,726)

—

(5,726)

Foreign currency forward contracts

The fair value of foreign currency forward contracts is determined using a market approach, which includes obtaining directly or indirectly observable values from third parties active in the relevant markets. Inputs in the fair value of the foreign currency forward contracts include prevailing forward and spot prices for currency.

5. Income Taxes

Income tax expense for the three months ended December ~~31, 2022~~30, 2023 was ~~$7.2~~$5.6 million compared to ~~$3.4~~$7.2 million for the three months ended ~~January 1,~~December 31, 2022.

The effective tax rates for the three months ended December 30, 2023 and December 31, 2022 were 16.2% and ~~January 1, 2022 were~~ 14.7% ~~and 12.5%~~, respectively. The effective tax rate for the three months ended December ~~31, 2022~~30, 2023 increased from the effective tax rate for the three months ended ~~January 1,~~December 31, 2022 primarily due to a change in the geographic distribution of pre-tax book income.

Table of Contents

The amount of unrecognized tax benefits recorded for uncertain tax positions increased by ~~$0.9~~$0.7 million for the three months ended December ~~31, 2022.~~30, 2023. The Company recognizes accrued interest and penalties on uncertain tax positions as a component of income tax expense. The amount of interest and penalties recorded for the three months ended December ~~31, 2022~~30, 2023 was not material.

One or more uncertain tax positions may be settled within the next 12 months. Settlement of these matters is not expected to have a material effect on the Company's consolidated results of operations, financial position and cash flows. The Company is not currently under examination by taxing authorities in the U.S. ~~The Company is under audit in a~~or any foreign ~~jurisdiction but a settlement is not expected to have a material impact.~~jurisdiction.

The Company maintains valuation allowances when it is more likely than not that all or a portion of a net deferred tax asset will not be realized. During the three months ended December ~~31, 2022,~~30, 2023, the Company continued to record a full valuation allowance against its net deferred tax assets in certain jurisdictions within the EMEA ~~segment~~and APAC segments and a partial valuation against its net deferred tax assets in certain jurisdictions within the AMER segment, as it was more likely than not that these assets would not be fully realized based primarily on historical performance. The Company will continue to provide a valuation allowance against its net deferred tax assets in each of the applicable jurisdictions going forward until it determines it is more likely than not that the deferred tax assets will be realized.

~~Table of Contents~~

6. Earnings Per Share

The following is a reconciliation of the amounts utilized in the computation of basic and diluted earnings per share for the three months ended December ~~31, 2022~~30, 2023 and ~~January 1,~~December 31, 2022 (in thousands, except per share amounts):


			Three Months Ended
		Three Months Ended							Three Months Ended
			December 31, 2022		January 1, 2022		December 30, 2023	December 31, 2022
Net income	Net income		$	42,190	$	23,423
Basic weighted average common shares outstanding	Basic weighted average common shares outstanding		27,639		28,018
Dilutive effect of share-based awards and options outstanding	Dilutive effect of share-based awards and options outstanding		666		691
Diluted weighted average shares outstanding	Diluted weighted average shares outstanding		28,305		28,709
Earnings per share:	Earnings per share:
Basic	Basic		$	1.53	$	0.84
Basic
Basic
Diluted	Diluted		$	1.49	$	0.82

For the three months ended December ~~31, 2022~~30, 2023 and ~~January 1,~~December 31, 2022, there were no antidilutive awards.

See also Note 12, "Shareholders' Equity," for information regarding the Company's share repurchase plans.

7. Leases

The components of lease expense for the three months ended December ~~31, 2022~~30, 2023 and ~~January 1,~~December 31, 2022 indicated were as follows (in thousands):

Three Months Ended

December 31, 2022

January 1, 2022

Three Months Ended

December 30,
2023

December 31,
2022

Finance lease expense:

Amortization of right-of-use assets

1,614

1,693

Interest on lease liabilities

1,272

1,222

Operating lease expense

2,606

2,857

Other lease expense

1,766

1,404

Total

7,258

7,176

Based on the nature of the ~~right-of use~~right-of-use ("ROU") asset, amortization of finance lease ROU assets, operating lease expense and other lease expense are recorded within either cost of goods sold or selling and administrative expenses and interest on finance

Table of Contents

lease liabilities is recorded within interest expense on the Condensed Consolidated Statements of Comprehensive Income. Other lease expense includes lease expense for leases with an estimated total term of twelve months or less and variable lease expense related to variations in lease payments as a result of a change in factors or circumstances occurring after the lease possession date.

~~Table of Contents~~

The following tables sets forth the amount of lease assets and lease liabilities included in the Company’s Condensed Consolidated Balance Sheets (in thousands):

Financial Statement Line Item

December 31, 2022

October 1, 2022

Financial Statement Line Item

December 30,
2023

September 30,
2023

ASSETS

Finance lease assets

Property, plant and equipment, net

38,025

40,063

Operating lease assets

Operating lease right-of-use assets

64,069

65,134

Total lease assets

102,094

105,197

LIABILITIES AND SHAREHOLDERS' EQUITY

Current

Finance lease liabilities

Current portion of long-term debt and finance lease obligations

4,406

5,087

Operating lease liabilities

Other accrued liabilities

8,878

7,948

Non-current

Finance lease liabilities

Long-term debt and finance lease obligations, net of current portion

38,583

39,257

Finance lease liabilities

Operating lease liabilities

Long-term operating lease liabilities

32,149

33,628

Total lease liabilities

84,016

85,920

8. Share-Based Compensation

The Company recognized ~~$5.8~~$5.3 million and ~~$6.3~~$5.8 million of compensation expense associated with share-based awards for the three months ended December ~~31, 2022~~30, 2023 and ~~January 1,~~December 31, 2022, respectively.

9. Litigation

The Company is party to lawsuits in the ordinary course of business. We record provisions in the consolidated financial statements for pending legal matters when we determine that an unfavorable outcome is probable, and the amount of the loss can be reasonably estimated.

Management does not believe that ~~these~~any such proceedings, individually or in the aggregate, will have a material positive or adverse effect on the Company’s consolidated financial position, results of operations or cash flows. However, legal proceedings and regulatory and governmental matters are subject to inherent uncertainties, and unfavorable rulings or other events could occur. Unfavorable resolutions could involve substantial fines, civil or criminal penalties, and other expenditures.

10. Reportable Segments

Reportable segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker ~~or group,~~ in assessing performance and allocating resources. The Company uses an internal management reporting system, which provides important financial data to evaluate performance and allocate the Company’s resources on a regional basis. Net sales for the segments are attributed to the region in which the product is manufactured or the service is performed. The services provided, manufacturing processes used, class of customers serviced and order fulfillment processes used are similar and generally interchangeable across the segments. A segment’s performance is evaluated based upon its operating ~~income (loss).~~income. A segment’s operating income ~~(loss)~~ includes its net sales less cost of sales and selling and administrative expenses, but excludes corporate and other expenses. Corporate and other expenses primarily represent corporate selling and administrative expenses, and restructuring costs and other charges, if any. These costs are not allocated to

Table of Contents

the segments, as management excludes such costs when assessing the performance of the segments. Inter-segment transactions are generally recorded at amounts that approximate arm’s length transactions. The accounting policies for the segments are the same as for the Company taken as a whole.

Information about the Company’s three reportable segments for the three months ended December 30, 2023 and December 31, 2022 is as follows (in thousands):


	Three Months Ended
	December 30, 2023		December 31, 2022
Net sales:
AMER	$	333,697	$	389,662
APAC	552,484		641,904
EMEA	121,938		89,373
Elimination of inter-segment sales	(25,512)		(27,014)
	$	982,607	$	1,093,925

Operating income (loss):
AMER	$	8,748	$	17,415
APAC	71,418		78,406
EMEA	(236)		(639)
Corporate and other costs	(34,772)		(37,841)
	45,158		57,341
Other income (expense):
Interest expense	(7,617)		(6,894)
Interest income	808		934
Miscellaneous, net	(3,502)		(1,944)
Income before income taxes	$	34,847	$	49,437


	December 30, 2023		September 30, 2023
Total assets:
AMER	$	1,089,798	$	1,124,555
APAC	1,665,865		1,696,795
EMEA	507,659		462,199
Corporate and eliminations	41,291		37,623
	$	3,304,613	$	3,321,172

1213

Table of Contents

~~Information about the Company’s three reportable segments for three months ended December 31, 2022 and January 1, 2022 is as follows (in thousands):~~

Three Months Ended
December 31, 2022 January 1, 2022
Net sales:
AMER $ 389,662 $ 277,346
APAC 641,904 491,672
EMEA 89,373 72,863
Elimination of inter-segment sales (27,014) (24,425)
$ 1,093,925 $ 817,456

Operating income (loss):
AMER $ 17,415 $ 1,790
APAC 78,406 60,688
EMEA (639) 956
Corporate and other costs (37,841) (32,961)
57,341 30,473
Other income (expense):
Interest expense (6,894) (3,046)
Interest income 934 271
Miscellaneous, net (1,944) (923)
Income before income taxes $ 49,437 $ 26,775

December 31,
2022 October 1,
2022
Total assets:
AMER $ 1,171,188 $ 1,150,605
APAC 1,809,364 1,807,542
EMEA 339,382 302,901
Corporate and eliminations 75,358 132,177
$ 3,395,292 $ 3,393,225

11. Guarantees

The Company offers certain indemnifications under its customer manufacturing agreements. In the normal course of business, the Company may from time to time be obligated to indemnify its customers or its customers’ customers against damages or liabilities arising out of the Company’s negligence, misconduct, breach of contract, or infringement of third-party intellectual property rights. Certain agreements have extended broader indemnification, and while most agreements have contractual limits, some do not. However, the Company generally does not provide for such indemnities and seeks indemnification from its customers for damages or liabilities arising out of the Company’s adherence to customers’ specifications or designs or use of materials furnished, or directed to be used, by its customers. The Company does not believe its obligations under such indemnities are material.

In the normal course of business, the Company also provides its customers a limited warranty covering workmanship, and in some cases materials, on products manufactured by the Company. Such warranty generally provides that products will be free from defects in the Company’s workmanship and meet mutually agreed-upon specifications for periods generally ranging from 12 months to 24 months. The Company’s obligation is generally limited to correcting, at its expense, any defect by repairing or replacing such defective product. The Company’s warranty generally excludes defects resulting from faulty customer-supplied components, design defects or damage caused by any party or cause other than the Company.

~~Table of Contents~~

The Company provides ~~for~~ an estimate of costs that may be incurred under its limited warranty at the time product revenue is recognized and establishes additional reserves for specifically identified product issues. These costs primarily include labor and materials, as necessary, associated with repair or replacement and are included in the Company's accompanying Condensed Consolidated Balance Sheets in "other accrued liabilities." The primary factors that affect the Company’s warranty liability include the value and the number of shipped units and historical and anticipated rates of warranty claims. As these factors are impacted by actual experience and future expectations, the Company assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary.

Below is a table summarizing the activity related to the Company’s limited warranty liability for the three months ended December 30, 2023 and December 31, 2022 ~~and~~ ~~January 1, 2022~~(in thousands):

Three Months Ended
December 31, 2022 January 1, 2022
Reserve balance, beginning of period $ 6,925 $ 6,645
Accruals for warranties issued during the period 727 1,258
Settlements (in cash or in kind) during the period (1,131) (741)
Reserve balance, end of period $ 6,521 $ 7,162


	Three Months Ended
	December 30, 2023		December 31, 2022
Reserve balance, beginning of period	$	5,821	$	6,925
Accruals for warranties issued during the period	946		727
Settlements (in cash or in kind) during the period	(277)		(1,131)
Reserve balance, end of period	$	6,490	$	6,521

12. Shareholders' Equity

On August 11, 2021, the Board of Directors approved a share repurchase program under which the Company was authorized to repurchase up to $50.0 million of its common stock (the "2022 Program"). The 2022 Program commenced upon completion of the 2021 Program and was completed in fiscal 2022. During the three months ended ~~January 1, 2022, the Company repurchased 110,440 shares under this program for $10.2 million at an average price of $91.74 per share.~~

On August 18, 2022, the Board of Directors approved a share repurchase program under which the Company is authorized to repurchase up to $50.0 million of its common stock (the "2023 Program"). The 2023 Program became effective immediately and has no expiration. During the three months ended December 30, 2023, the Company repurchased no shares under this program. During the three months ended December 31, 2022, the Company repurchased 115,723 shares under this program for $11.5 million at an average price of $99.12 per share. As of December ~~31, 2022, $35.0~~30, 2023, $5.7 million of authority remained under the 2023 Program.

All shares repurchased under the aforementioned ~~programs~~program were recorded as treasury stock.

Refer to Note 15, "Subsequent Events," for further information regarding the 2024 Program announced by the Company on January 16, 2024.

Table of Contents

13. Trade Accounts Receivable Sale Programs

The Company has Master Accounts Receivable Purchase Agreements with MUFG Bank, New York Branch (formerly known as The Bank of Tokyo-Mitsubishi UFJ, Ltd.) (the "MUFG RPA"), HSBC Bank (China) Company Limited, Xiamen branch (the "HSBC RPA") and other unaffiliated financial institutions, under which the Company may elect to sell ~~receivables;~~receivables at a discount. All facilities are uncommitted facilities. The maximum facility amount under the MUFG RPA is $340.0 million. The maximum facility amount under the HSBC RPA is ~~$60.0~~$70.0 million. The MUFG RPA will be automatically extended each year unless any party gives no less than 10 days prior notice that the agreement should not be extended. The terms of the HSBC RPA are generally consistent with the terms of the MUFG ~~RPA previously discussed.~~RPA.

Transfers of receivables under the programs are accounted for as sales and, accordingly, receivables sold under the programs are excluded from accounts receivable on the Condensed Consolidated Balance Sheets and are reflected as cash provided by operating activities on the Condensed Consolidated Statements of Cash Flows. Proceeds from the transfer reflect the face value of the receivables less a discount. The sale discount is recorded within "Miscellaneous, net" in the Condensed Consolidated Statements of Comprehensive Income in the period of the sale. The Company continues servicing receivables sold and performing all accounts receivable administrative functions, ~~and~~ in exchange receives a servicing fee, under both the MUFG RPA and HSBC RPA. Servicing fees related to trade accounts receivable programs recognized during the three months ended December 30, 2023 and December 31, 2022 ~~and January 1, 2022~~were not material.

The Company sold ~~$185.6~~$223.6 million and ~~$148.0~~$185.6 million of trade accounts receivable under these programs, or their predecessors, during the three months ended December 30, 2023 and December 31, 2022, ~~and January 1, 2022,~~ respectively, in exchange for cash proceeds of ~~$183.6~~$221.0 million and~~$147.5~~ $183.6 million, respectively. As of December ~~31, 2022~~30, 2023 and ~~January 1,~~December 31, 2022,, $226.9 million and $196.8 million, ~~and $151.0 million,~~

~~Table of Contents~~

respectively, of accounts receivables sold under trade accounts receivable programs and subject to servicing by the Company remained outstanding and had not yet been ~~collected.~~collected by MUFG Bank or HSBC Bank.

14. Revenue from Contracts with Customers

Revenue is recognized over time for arrangements with customers for which: (i) the Company's performance does not create an asset with an alternative use to the Company, and (ii) the Company has an enforceable right to payment, including reasonable profit margin, for performance completed to date. Revenue recognized over time is estimated based on costs incurred to date plus a reasonable profit margin. If either of the two conditions noted above are not met to recognize revenue over time, revenue is recognized following the transfer of control of such products to the customer, which typically occurs upon shipment or delivery depending on the terms of the underlying arrangement.

The Company recognizes revenue when a contract exists and when, or as, it satisfies a performance obligation by transferring control of a product or service to a customer. Contracts are accounted for when they have approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer.

The Company generally enters into a master services arrangement that establishes the framework under which business will be conducted. These arrangements represent the master terms and conditions of the Company's services that apply to individual orders, but they do not commit the customer to work with, or to continue to work with, the Company nor do they obligate the customer to any specific volume or pricing of purchases. Moreover, these terms can be amended in appropriate situations.

Customer purchase orders are received for specific quantities with predominantly fixed pricing and delivery requirements. Thus, for the majority of our contracts, there is no guarantee of any revenue to the Company until a customer submits a purchase order. As a result, the Company generally considers its arrangement with a customer to be the combination of the master services arrangement and the purchase order. Most of the Company's arrangements with customers create a single performance obligation as the promise to transfer the individual manufactured product or service is capable of being distinct.

The Company’s performance obligations are satisfied over time as work progresses or at a point in time. A performance obligation is satisfied over time if the Company has an enforceable right to payment, including a reasonable profit margin. Determining if an enforceable right to payment includes a reasonable profit margin requires judgment and is assessed on a ~~contract by contract~~contract-by-contract basis.

Generally, there are no subjective customer acceptance requirements or further obligations related to goods or services provided; if such requirements or obligations exist, then a sale is recognized at the time when such requirements are completed and such obligations are fulfilled.

Table of Contents

The Company does not allow for a general right of return. Net sales include amounts billed to customers for shipping and handling and out-of-pocket expenses. The corresponding shipping and handling costs and out-of-pocket expenses are included in cost of sales. Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by the Company from a customer, are excluded from net sales.

Contract Costs

For contracts requiring over time revenue recognition, the selection of the method to measure progress ~~towards~~toward completion requires judgment and is based on the nature of the products or services to be provided. The Company uses a cost-based input measurement of progress because it best depicts the transfer of assets to the customer, which occurs as costs are incurred during the manufacturing process or as services are rendered. Under the cost-based measure of progress, the extent of progress ~~towards~~toward completion is measured based on the costs incurred to date.

There were no other costs to obtain or fulfill customer contracts.

~~Table of Contents~~

Disaggregated Revenue

The table below includes the Company’s revenue for the ~~three months ended December 31, 2022 and January 1, 2022~~fiscal years indicated disaggregated by geographic reportable segment and market sector (in thousands):


			Three Months Ended
			December 31, 2022
			Reportable Segment:
			AMER		APAC		EMEA		Total
		Three Months Ended											Three Months Ended
		December 30, 2023											December 30, 2023
		Reportable Segment:											Reportable Segment:
		AMER									AMER	APAC	EMEA	Total
Market Sector:	Market Sector:
Healthcare/Life Sciences
Healthcare/Life Sciences
Healthcare/Life Sciences
Industrial	Industrial		$	103,027	$	350,584	$	18,471	$	472,082
Healthcare/Life Sciences			215,381		223,290		49,196		487,867
Aerospace/Defense	Aerospace/Defense		68,022		45,654		20,300		133,976
External revenue	External revenue		386,430		619,528		87,967		1,093,925
Inter-segment sales	Inter-segment sales		3,232		22,376		1,406		27,014
Segment revenue	Segment revenue		$	389,662	$	641,904	$	89,373	$	1,120,939


			Three Months Ended
			January 1, 2022
			Reportable Segment:
			AMER		APAC		EMEA		Total
		Three Months Ended											Three Months Ended
		December 31, 2022											December 31, 2022
		Reportable Segment:											Reportable Segment:
		AMER									AMER	APAC	EMEA	Total
Market Sector:	Market Sector:
Healthcare/Life Sciences
Healthcare/Life Sciences
Healthcare/Life Sciences
Industrial	Industrial		$	83,245	$	265,275	$	15,307	$	363,827
Healthcare/Life Sciences			135,962		169,237		39,266		344,465
Aerospace/Defense	Aerospace/Defense		55,750		35,743		17,671		109,164
External revenue	External revenue		274,957		470,255		72,244		817,456
Inter-segment sales	Inter-segment sales		2,389		21,417		619		24,425
Segment revenue	Segment revenue		$	277,346	$	491,672	$	72,863	$	841,881

For ~~each of~~ the three months ended December 30, 2023 and December 31, 2022, approximately 84% and ~~January 1, 2022, approximately~~ 81% ~~and 87%~~, respectively, of the Company's revenue ~~respectively,~~ was recognized as products and services ~~were~~ transferred over time.

Contract Balances

The timing of revenue recognition, billings and cash collections results in billed accounts receivable, contract assets and deferred revenue on the Company’s accompanying Condensed Consolidated Balance Sheets.

Contract Assets: For performance obligations satisfied at a point in time, billing occurs subsequent to revenue recognition, at which point the customer has been billed and the resulting asset is recorded within accounts receivable. For performance obligations satisfied over time as work progresses, the Company has an unconditional right to payment, which results in the

Table of Contents

recognition of contract assets. The following table summarizes the activity in the Company's contract assets during the three months ended December ~~31, 2022~~30, 2023 and ~~January 1,~~December 31, 2022 (in thousands):


			Three Months Ended
			December 31, 2022		January 1, 2022
		Three Months Ended						Three Months Ended
		December 30, 2023					December 30, 2023		December 31, 2022
Contract assets, beginning of period	Contract assets, beginning of period		$	138,540	$	115,283
Revenue recognized during the period	Revenue recognized during the period		884,099		709,723
Amounts collected or invoiced during the period	Amounts collected or invoiced during the period		(903,623)		(719,556)
Contract assets, end of period	Contract assets, end of period		$	119,016	$	105,450

Deferred Revenue: Deferred revenue is recorded when consideration is received from a customer prior to transferring goods or services to the customer under the terms of the contract, which is included in ~~other accrued liabilities~~advanced payments from customers on Condensed

~~Table of Contents~~

Consolidated Balance Sheets. As of December ~~31, 2022~~30, 2023 and ~~October 1, 2022~~September 30, 2023, the balance of advance payments from customers attributable to deferred revenue was ~~$247.1~~$159.4 million and ~~$298.8~~$158.7 million, respectively. The advance payment is not considered a significant financing component because it is used to meet working capital demands that can be higher in the early stages of a contract and to protect the company from the other party failing to adequately complete some or all of its obligations under the contract. Deferred revenue is recognized into revenue when all revenue recognition criteria are met. For performance obligations satisfied over time, recognition will occur as work progresses; otherwise deferred revenue will be recognized based upon shipping ~~terms.~~terms

15. ~~Restructuring~~Subsequent Events

On January 16, 2024, the Company announced an additional $50.0 million in share repurchase authority (the "2024 Program") that authorizes the repurchase of its common stock, leaving $55.7 million in repurchase authority available under the combined 2023 and ~~Impairment Charges~~

~~Restructuring and impairment charges are recorded within restructuring and impairment charges on~~2024 Programs. The 2024 Program will commence upon completion of the ~~Condensed Consolidated Statements of Comprehensive Income. Restructuring liabilities are recorded within other accrued liabilities on the Condensed Consolidated Balance Sheets.~~2023 Program.

During January 2024, the ~~first~~Company committed to a restructuring plan and anticipates incurring approximately $10.0 million of restructuring charges, which are primarily severance cash charges, during the second quarter of fiscal 2023, the Company did not incur any restructuring and impairment charges. During the first quarter of fiscal 2022, the Company recorded $2.0 million of restructuring and impairment charges primarily due to employee severance costs associated with a facility transition in the Company's APAC segment.

~~The Company recognized a tax benefit of $0.2 million related to restructuring and impairment charges for the three months ended January 1, 2022.~~

~~The Company's restructuring accrual activity for the three months ended January 1, 2022 is included in the tables below (in thousands):~~

Fixed Asset and Operating ROU Asset Impairment Employee Termination and Severance Costs Total
Accrual balance, as of October 2, 2021 $ — $ 71 $ 71
Restructuring and impairment costs 255 1,766 2,021
Amounts utilized (255) (75) (330)
Accrual balance, as of January 1, 2022 $ — $ 1,762 $ 1,762
2024.

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

"SAFE HARBOR" CAUTIONARY STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995:

The statements contained in this Form 10-Q that are guidance or which are not historical facts (such as statements in the future tense and statements including believe, expect, intend, plan, anticipate, goal, target and similar terms and concepts), including all discussions of periods which are not yet completed, are forward-looking statements that involve risks and uncertainties. These risks and uncertainties include the effect of inflationary pressures on our costs of production, profitability, and on the economic outlook of our markets; the effects of shortages and delays in obtaining components as a result of economic cycles, natural disasters or otherwise; the risk of customer delays, changes, cancellations or forecast inaccuracies in both ongoing and new programs; the effects of our Xiamen, China subsidiary being placed on the Bureau of Industry and Security's Unverified list; the ability to realize anticipated savings from restructuring or similar actions, as well as the adequacy of related charges as compared to actual expenses; the lack of visibility of future orders, particularly in view of changing economic conditions; the economic performance of the industries, sectors and customers we serve; the outcome of litigation and regulatory investigations and proceedings, including the results of any challenges with regard to such outcomes; the effects of tariffs, trade disputes, trade agreements and other trade protection measures; the effects of the volume of revenue from certain sectors or programs on our margins in particular periods; our ability to secure new customers, maintain our current customer base and deliver product on a timely basis; the risks of concentration of work for certain customers; the particular risks relative to new or recent customers, programs or services, which risks include customer and other delays, start-up costs, potential inability to execute, the establishment of appropriate terms of agreements, and the lack of a track record of order volume and timing; the effects of start-up costs of new programs and facilities or the costs associated with the closure or consolidation of facilities; possible unexpected costs and operating disruption in transitioning programs, including transitions between Company facilities; the risk that new program wins and/or customer demand may not result in the expected revenue or profitability; the fact that customer orders may not lead to long-term relationships; our ability to manage successfully and execute a complex business model characterized by high product mix and demanding quality, regulatory, and other requirements; the risks associated with excess and obsolete inventory, including the risk that inventory purchased on behalf of our customers may not be consumed or otherwise paid for by the customer, resulting in an inventory write-off; risks related to information technology systems and data security; ~~the ability to realize anticipated savings from restructuring or similar actions, as well as the adequacy of related charges as compared to actual expenses;~~ increasing regulatory and compliance requirements; any tax law changes and related foreign jurisdiction tax developments; current or potential future barriers to the repatriation of funds that are currently held outside of the United States as a result of actions taken by other countries or otherwise; the potential effects of jurisdictional results on our taxes, tax rates, and our ability to use deferred tax assets and net operating losses; the weakness of areas of the global economy; the effect of changes in the pricing and margins of products; raw materials and component cost fluctuations; the potential effect of fluctuations in the value of the currencies in which we transact business; the effects of changes in economic conditions, political conditions and tax matters in the United States and in the other countries in which we do business; the potential effect of other world or local events or other events outside our control (such as the conflict between Russia and Ukraine, conflict in the Middle East, escalating tensions between China and Taiwan or China and the United States, changes in energy prices, terrorism, global health epidemics and weather events); the impact of increased competition; an inability to successfully manage human capital; changes in financial accounting standards; and other risks detailed herein and in our other Securities and Exchange Commission filings, particularly in Risk Factors contained in our fiscal ~~2022~~2023 Form 10-K.

* * *

Table of Contents

OVERVIEW

Plexus Corp. and its subsidiaries (together "Plexus," the "Company", "our", or "we") participate in the Electronic Manufacturing Services ("EMS") industry. Since 1979, we have been partnering with companies to create the products that build a better world. We are a global leader with a team of ~~nearly 25,000~~over 20,000 individuals who are dedicated to providing Design and Development, Supply Chain Solutions, New Product Introduction, Manufacturing and Sustaining Services. We specialize in serving customers in industries with highly complex products and demanding regulatory environments. We deliver customer service excellence to leading global companies in the ~~Industrial,~~ Healthcare/Life Sciences, Industrial and Aerospace/Defense market sectors by providing innovative, comprehensive solutions throughout the product's lifecycle. We provide these innovative solutions to customers in the Americas ("AMER"), Asia-Pacific ("APAC") and Europe, Middle East and Africa ("EMEA") regions.

The following Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") is intended to provide an analysis of both short-term results and future prospects from management’s perspective, including an assessment of the financial condition and results of operations, events and uncertainties that are not indicative of future operations and any other financial or statistical data that we believe will enhance the understanding of our company’s financial condition, cash flows and other changes in financial condition and results of ~~operations.~~

operations

The following information should be read in conjunction with our condensed consolidated financial statements included herein and "Risk Factors" included in Part II, Item 1A included herein as well as Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended ~~October 1, 2022,~~September 30, 2023, and our "Safe Harbor" Cautionary Statement included above.

Market Pressures Update

We have experienced an inability to procure certain components on a timely basis due to global supply chain constraints. These constraints have impacted our ability to meet customer demand and may inhibit our ability to capture the demand from our customers. The extended lead-times have required us to make additional investments in inventory to satisfy customer ~~demand, which we expect to persist.~~

Over the past few quarters, the global supply chain constraints have led to inflation in some of the components we acquire, as well as labor and operating costs. We expect the increase in costs, including labor-related issues which have become more pronounced, to continue in the near future. We have been, and expect to continue to be, subject to such inflationary and general labor cost increases. While we have been largely able to mitigate the impacts of inflation through our contractual rights with customers on pricing, the pricing recoveries received may be dilutive to our operating margin. The inability to offset these costs in future periods or the impacts of continued inflation on end markets and our customers may affect our operating results, cash flows and inventory levels, which could increase as a result of higher component prices or the negative effects of inflation on customer end-market demand.

Customers within certain segments are working to better understand the impact of the Department of Commerce’s export controls restricting the People’s Republic of China’s access to advanced semiconductors, supercomputers, and semiconductor manufacturing equipment. We could continue to see demand volatility as they adjust their forecasts as a result of these restrictions.

Changes in tax laws or tax rates in the jurisdictions where we operate, including the potential passage of tax regulation changes such as the establishment of a global minimum tax could result in adverse tax consequences. During the first quarter of fiscal ~~2023,~~2024, we have experienced market-driven inventory corrections at our customers inventory corrections at the customers and incrementally weaker demand from the Healthcare/Lifesciences and Industrial market sectors creating inefficiencies within our operations. We expect the market-driven inventory corrections at the customers and weaker demand in certain ~~jurisdictions consented~~sectors to ~~implement~~be a near-term challenge that will lessen later in fiscal 2024. However, if market softness continues for extended periods, this would impact our operating results in future periods.

A global minimum ~~tax.~~tax has been, or is anticipated to be, implemented in many of the countries in which we operate. We anticipate this will materially and unfavorably impact our existing tax holidays and effective tax rate beginning in our fiscal 2025. We will continue to monitor these developments as each jurisdiction incorporates such changes into tax laws.

We believe our balance sheet is positioned to support the potential future challenges presented by the macro-economic pressures we are facing. As of the first quarter of fiscal ~~2023,~~2024, cash and cash equivalents and restricted cash were ~~$248~~$232 million, while debt, finance lease obligations and other financing were ~~$516~~$443 million. Borrowings under our Credit Facility as of December ~~31, 2022~~30, 2023 were ~~$320~~$243.0 million, leaving ~~$180~~$257 million of our revolving commitment of $500 million available for use as well as the ability to expand our revolving commitment to $750 million upon mutual agreement with the bank. Interest expense could increase above current levels due to increased borrowing under our Credit Facility associated with working capital investments along with the impact of rising interest rates. Refer to Note 3, "Debt, Finance Lease and Other Financing Obligations," in Notes to Condensed Consolidated Financial Statements and "Management’s Discussion and Analysis Liquidity and Capital Resources" in Part I, Item 2 for further information.

Table of Contents

RESULTS OF OPERATIONS

Consolidated Performance Summary. The following table presents selected consolidated financial data (dollars in millions, except per share data):


			Three Months Ended
			December 31, 2022			January 1, 2022
		Three Months Ended													Three Months Ended
		December 30, 2023										December 30, 2023				December 31, 2022
Net sales	Net sales		$	1,093.9		$	817.5
Cost of sales	Cost of sales		992.7			747.5
Gross profit	Gross profit		101.2			70.0
Gross margin	Gross margin		9.3		%	8.6		%	Gross margin	9.0	%		9.3	%
Operating income	Operating income		57.3			30.5
Operating margin	Operating margin		5.2		%	3.7		%	Operating margin	4.6	%		5.2	%
Other expense	Other expense		7.9			3.7
Income tax expense	Income tax expense		7.2			3.4
Net income	Net income		42.2			23.4
Diluted earnings per share	Diluted earnings per share		$	1.49		$	0.82
Return on invested capital*	Return on invested capital*		13.8		%	10.0		%	Return on invested capital*	10.3	%		13.8	%
Economic return*	Economic return*		4.8		%	0.7		%	Economic return*	2.1	%		4.8	%
*Non-GAAP metric; refer to "Return on Invested Capital ("ROIC") and economic return" below and Exhibit 99.1 for more information.	*Non-GAAP metric; refer to "Return on Invested Capital ("ROIC") and economic return" below and Exhibit 99.1 for more information.								*Non-GAAP metric; refer to "Return on Invested Capital ("ROIC") and economic return" below and Exhibit 99.1 for more information.

Net sales. For the three months ended December ~~31, 2022,~~30, 2023, net sales ~~increased $276.4~~decreased $111.3 million, or ~~33.8%~~10.2%, as compared to the three months ended ~~January 1,~~December 31, 2022.

Net sales are analyzed by management by geographic segment, which reflects our reportable segments, and by market sector. Management measures operational performance and allocates resources on a geographic segment basis. Our global business development strategy is based on our targeted market sectors.

A discussion of net sales by reportable segment is presented below (in millions):

Three Months Ended
December 31, 2022 January 1, 2022
Net sales:
AMER $ 389.7 $ 277.3
APAC 641.9 491.7
EMEA 89.4 72.9
Elimination of inter-segment sales (27.1) (24.4)
Total net sales $ 1,093.9 $ 817.5


	Three Months Ended
	December 30, 2023		December 31, 2022
Net sales:
AMER	$	333.7	$	389.7
APAC	552.5		641.9
EMEA	121.9		89.4
Elimination of inter-segment sales	(25.5)		(27.1)
Total net sales	$	982.6	$	1,093.9

AMER. Net sales for the three months ended December ~~31, 2022~~30, 2023 in the AMER segment ~~increased $112.4~~decreased $56.0 million, or ~~40.5%~~14.4%, as compared to the three months ended ~~January 1,~~December 31, 2022. The ~~increase~~decrease in net sales was driven by ~~a $68.2 million increase in production ramps of new products for existing customers and~~ overall net ~~increased~~decreased customer end-market demand inclusive of ~~a partial easing of supply chain constraints that had previously created limitations with meeting available customer demand. The increase was also driven by higher pricing associated with~~market-driven inventory corrections at the customers as well as reductions in inflated component ~~prices and~~pricing. The decrease was partially offset by an ~~$11.0~~increase of $8.7 million ~~increase in~~due to production ramps for new customers.

APAC. Net sales for the three months ended December ~~31, 2022~~30, 2023 in the APAC segment ~~increased $150.2~~decreased $89.4 million, or ~~30.5%~~13.9%, as compared to the three months ended ~~January 1,~~December 31, 2022. The decrease in net sales was driven by overall net decreased customer end-market demand inclusive of market-driven inventory corrections at the customers as well as reductions in inflated component pricing, partially offset by a partial easing of supply chain constraints. The decrease was further offset by a $12.3 million increase due to production ramps of new products for existing customers.

EMEA. Net sales for the three months ended December 30, 2023 in the EMEA segment increased $32.5 million, or 36.4%, as compared to the three months ended December 31, 2022. The increase in net sales was driven by a $15.6 million increase due to production ramps for a new customer and overall net increased customer end-market ~~demand inclusive of a partial easing of supply chain constraints that had previously created limitations with meeting available customer~~ demand. The increase was ~~also driven by higher pricing associated with inflated component prices and a $5.0 million increase in production ramps of new products for existing customers.~~further

Table of Contents

~~EMEA.~~
~~Net sales for the three months ended December 31, 2022 in the EMEA segment increased $16.5~~

driven by a $5.2 million ~~or 22.6%, as compared to the three months ended January 1, 2022. The~~ increase in ~~net sales was driven~~production ramps of new products for existing customers, partially offset by ~~overall net increased customer end-market demand and increased pricing associated with~~reductions in inflated component ~~prices.~~pricing.

Our net sales by market sector for the indicated fiscal period were as follows (in millions):

Three Months Ended
December 31, 2022 January 1, 2022
Net sales:
Industrial $ 472.1 $ 363.8
Healthcare/Life Sciences 487.9 344.5
Aerospace/Defense 133.9 109.2
Total net sales $ 1,093.9 $ 817.5

~~Industrial.~~ Net sales for the three months ended December 31, 2022 in the Industrial sector increased $108.3 million, or 29.8%, as compared to the three months ended January 1, 2022. The increase in net sales was driven by overall net increased customer end-market demand inclusive of a partial easing of supply chain constraints that had previously created limitations with meeting available customer demand. The increase was also driven by higher pricing associated with inflated component prices, a $7.7 million increase in production ramps for new customers and a $7.6 million increase due to production ramps of new products for existing customers.


	Three Months Ended
	December 30, 2023		December 31, 2022
Net sales:
Healthcare/Life Sciences	$	380.9	$	487.9
Industrial	434.6		472.1
Aerospace/Defense	167.1		133.9
Total net sales	$	982.6	$	1,093.9

Healthcare/Life Sciences. Net sales for the three months ended December ~~31, 2022~~30, 2023 in the Healthcare/Life Sciences sector ~~increased $143.4~~decreased $107.0 million, or ~~41.6%~~21.9%, as compared to the three months ended ~~January 1,~~December 31, 2022. The ~~increase~~decrease in net sales was driven by overall net ~~increased~~decreased customer end-market demand inclusive of market-driven inventory corrections at the customers as well as a ~~partial easing of supply chain constraints that had previously created limitations with meeting available customer demand. The increase was also driven by higher pricing associated with~~reduction in inflated component ~~prices and a $58.5~~pricing. The decrease was partially offset by an increase of $9.1 million ~~increase~~ due to production ramps of new products for existing customers.

Industrial. Net sales for the three months ended December 30, 2023 in the Industrial sector decreased $37.5 million, or 7.9%, as compared to the three months ended December 31, 2022. The decrease in net sales was driven by overall net decreased customer end-market demand inclusive of market-driven inventory corrections at the customers as well as reductions in inflated component pricing. The decrease was partially offset by an increase of $20.7 million due to production ramps for new customers.

Aerospace/Defense. Net sales for the three months ended December ~~31, 2022~~30, 2023 in the Aerospace/Defense sector increased ~~$24.7~~$33.2 million, or ~~22.6%~~24.8%, as compared to the three months ended ~~January 1,~~December 31, 2022. The increase was driven by overall net increased customer end-market demand and ~~increased pricing associated with inflated component prices, a $7.8~~an $8.0 million increase due to production ramps of new products for existing ~~customers and~~customers. The increase was partially offset by a ~~$7.6 million increase~~reduction in ~~production ramps for a new customer.~~inflated component pricing.

Cost of sales. Cost of sales for the three months ended December ~~31, 2022 increased $245.2~~30, 2023 decreased $98.2 million, or ~~32.8%~~9.9%, as compared to the three months ended ~~January 1,~~December 31, 2022. Cost of sales is comprised primarily of material and component costs, labor costs and overhead. For the three months ended December ~~31, 2022~~30, 2023 and ~~January 1,~~December 31, 2022, approximately 89% to 91% of the total cost of sales was variable in nature and fluctuated with sales volumes. Approximately 87% to 88% of these costs were related to material and component costs.

As compared to the three months ended ~~January 1,~~December 31, 2022, the ~~increase~~decrease in cost of sales for the three months ended December ~~31, 2022~~30, 2023 was primarily driven by the ~~increase~~decrease in net sales ~~inflated component costs~~ and a positive shift in customer mix, partially offset by an increase in fixed ~~costs, partially offset by improvements in operational efficiencies.~~costs.

Gross profit. Gross profit for the three months ended December ~~31, 2022 increased $31.2~~30, 2023 decreased $13.1 million, or ~~44.6%~~12.9%, as compared to the three months ended ~~January 1,~~December 31, 2022. Gross margin of ~~9.3%~~9.0% for the three months ended December ~~31, 2022 increased 70~~30, 2023 decreased 30 basis points compared to the three months ended ~~January 1,~~December 31, 2022. The primary ~~driver~~drivers of the ~~increase~~decrease in gross profit and gross margin ~~was~~as compared to the ~~increase~~three months ended December 31, 2022 were the decrease in net sales and ~~improvements~~an increase in ~~operational efficiencies,~~fixed costs to support new customer program ramps, partially offset by ~~inflated component costs and increased fixed costs.~~a positive shift in customer mix.

Operating income. Operating income for the three months ended December ~~31, 2022 increased $26.8~~30, 2023 decreased $12.1 million, or ~~87.9%~~21.1%, as compared to the three months ended ~~January 1,~~December 31, 2022. Operating margin of ~~5.2%~~4.6% for the three months ended December ~~31, 2022 increased 150~~30, 2023 decreased 60 basis points compared to the three months ended ~~January 1,~~December 31, 2022. The primary driver of the ~~increase~~decrease in operating income and operating margin for the three months ended December 30, 2023 was the result of the ~~increase~~decrease in gross ~~profit and gross~~ margin ~~along with a $2.0 million decrease in restructuring and impairment charges,~~ partially offset by a ~~$6.4~~$0.9 million ~~increase~~decrease in selling and administrative expenses ("S&A"). The ~~increase~~decrease in S&A was primarily due to ~~an increase~~a decrease in incentive compensation costs.

Table of Contents

A discussion of operating income by reportable segment ~~presented below (in~~for the indicated fiscal period(in millions):

Three Months Ended

December 31, 2022

January 1, 2022

Operating income (loss):

Three Months Ended

December 30,
2023

December 31,
2022

Operating income:

AMER

17.4

1.8

APAC

78.4

60.7

EMEA

(0.6)

1.0

Corporate and other costs

(37.9)

(33.0)

Total operating income

57.3

30.5

AMER. Operating income ~~increased $15.6~~decreased $8.7 million for the three months ended December ~~31, 2022~~30, 2023 as compared to the three months ended ~~January 1,~~December 31, 2022 primarily as a result of a decrease in net sales, partially offset by a positive shift in customer mix.

APAC. Operating income decreased $7.0 million for the three months ended December 30, 2023 as compared to the three months ended December 31, 2022 primarily as a result of a decrease in net sales, partially offset by a positive shift in customer mix and a decrease in S&A.

EMEA. Operating income increased $0.4 million for the three months ended December 30, 2023 as compared to the three months ended December 31, 2022 primarily as a result of an increase in net sales, ~~and improvements in operational efficiencies,~~ partially offset by ~~inflated component costs and~~ increased fixed costs.

~~APAC.~~ Operating income increased $17.7 million for the three months ended December 31, 2022 as compared to the three months ended January 1, 2022, primarily as a result of an increase in net sales and improvements in operational efficiencies, partially offset by inflated component costs, increased fixed costs and an increase in S&A.

~~EMEA.~~ Operating income decreased $1.6 million for the three months ended December 31, 2022 as compared to the three months ended January 1, 2022 primarily as a result of inflated component costs and a negative shift in customer mix, partially offset by an increase in net sales.

Other expense. Other expense for the three months ended December ~~31, 2022~~30, 2023 increased ~~$4.2~~$2.4 million as compared to the three months ended ~~January 1,~~December 31, 2022. The increase in other expense for the three months ended December ~~31, 2022~~30, 2023 was primarily ~~due to the~~driven by a decrease in other miscellaneous income of $0.9 million, an increase in interest expense of ~~$3.8~~$0.7 million due to a higher average interest rate and the higher average daily borrowing levels and an increase in factoring fees of ~~$1.5~~$0.6 million.

Income taxes. Income tax expense for the three months ended December ~~31, 2022~~30, 2023 was ~~$7.2~~$5.6 million compared to ~~$3.4~~$7.2 million for the three months ended ~~January 1,~~December 31, 2022. The ~~increase~~decrease is primarily due to ~~an increase~~a decrease in ~~pre-tax book income and change in the geographic distribution of~~ pre-tax book income.

Our annual effective tax rate varies from the U.S. statutory rate of 21.0% primarily due to the geographic distribution of worldwide earnings as well as a tax holiday granted to a subsidiary located in the APAC segment where we derive a significant portion of our earnings. Our effective tax rate may also be impacted by disputes with taxing authorities, tax planning activities, adjustments to uncertain tax positions and changes in valuation allowances.

The annual effective tax rate for fiscal ~~2023~~2024 is expected to be approximately ~~14.0%~~15.0% to ~~16.0%~~17.0% assuming no changes to tax laws.

Net Income. Net income for the three months ended December ~~31, 2022 increased $18.8~~30, 2023 decreased $13.0 million, or ~~80.3%~~30.8%, ~~from~~for the three months ended ~~January 1,~~December 31, 2022 to ~~$42.2~~$29.2 million. Net income ~~increased~~decreased primarily as a result of the decrease in operating income and the increase in other expense, partially offset by ~~an increase~~the decrease in tax ~~expense and other~~ expense as previously discussed.

Diluted earnings per share. Diluted earnings per share ~~increased~~decreased to $1.04 for the three months ended December 30, 2023 from $1.49 for the three months ended December 31, 2022 ~~from $0.82 for the three months ended January 1, 2022,~~ primarily as a result of ~~increased~~decreased net income due to the factors ~~previously~~ discussed ~~as well as~~above, partially offset by a reduction in diluted shares ~~outstanding due to repurchase activity under our share repurchase plans.~~outstanding.

Return on Invested Capital ("ROIC") and economic return. We use a financial model that is aligned with our business strategy and includes an ROIC goal of 15% which would exceed our weighted average cost of capital ("WACC") by more than 500 basis points and represent positive economic return. Economic return is the amount our ROIC exceeds our WACC.

Non-GAAP financial measures, including ROIC and economic return, are used for internal management goals and decision making because such measures provide management and investors additional insight into financial performance. In particular, we provide ROIC and economic return because we believe they offer insight into the metrics that are driving management decisions. We view ROIC and economic return as important measures in evaluating the efficiency and effectiveness of our long-term capital investments. We also use ROIC as a performance criteria in determining certain elements of compensation as well as economic return performance.

We define ROIC as tax-effected operating income before restructuring and other special items divided by average invested capital over a rolling two-quarter period for the first ~~quarter.~~period. Invested capital is defined as equity plus debt and operating lease

~~Table of Contents~~

liabilities, less cash and cash equivalents. Other companies may not define or calculate ROIC in the same way. ROIC and other

Table of Contents

non-GAAP financial measures should be considered in addition to, not as a substitute for, measures of our financial performance prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP").

We review our internal calculation of WACC annually. Our WACC is 8.2% for fiscal 2024 and 9.0% for fiscal ~~2023 as compared to 9.3% for fiscal 2022.~~2023. By exercising discipline to generate ROIC in excess of our WACC, our goal is to create value for our shareholders. For the three months ended December 30, 2023, ROIC of 10.3% reflects an economic return of 2.1%, based on our WACC of 8.2%, and for the three months ended December 31, 2022, ROIC of 13.8% reflects an economic return of 4.8%, based on our weighted average cost of capital of 9.0%. ~~For the three months ended January 1, 2022, ROIC of 10.0% reflects an economic return of 0.7%, based on our weighted average cost of capital of 9.3% for that fiscal year.~~

For a reconciliation of ROIC, economic return and adjusted operating income (tax-effected) to our financial statements that were prepared using U.S. GAAP, see Exhibit 99.1 to this quarterly report on Form 10-Q, which exhibit is incorporated herein by reference.

Refer to the table below, which includes the calculation of ROIC and economic return for the indicated fiscal period (dollars in millions):

Three Months Ended
December 31, 2022 January 1, 2022
Adjusted operating income (tax-effected) $ 192.7 $ 113.1
Average invested capital 1,392.0 1,135.3
After-tax ROIC 13.8 % 10.0 %
WACC 9.0 % 9.3 %
Economic return 4.8 % 0.7 %


	Three Months Ended
	December 30, 2023			December 31, 2022
Adjusted operating income (tax-effected)	$	151.7		$	192.7
Average invested capital	1,479.6			1,392.0
After-tax ROIC	10.3		%	13.8		%
WACC	8.2		%	9.0		%
Economic return	2.1		%	4.8		%

LIQUIDITY AND CAPITAL RESOURCES

Cash and cash equivalents and restricted cash were ~~$247.9~~$232.4 million as of December ~~31, 2022,~~30, 2023 as compared to ~~$275.5~~$256.7 million as of ~~October 1, 2022.~~September 30, 2023.

As of December ~~31, 2022, 87%~~30, 2023, 90% of our cash and cash equivalents balance was held outside of the U.S. by our foreign subsidiaries. Currently, we believe that our cash balance, together with cash available under our Credit Facility, will be sufficient to meet our liquidity needs and potential share repurchases ~~if any,~~ for the next twelve months and ~~for~~ the foreseeable future.

Our future cash flows from operating activities will be reduced by ~~$47.7~~$42.0 million due to cash payments for U.S. federal taxes on the deemed repatriation of undistributed foreign earnings that are payable over an ~~eight-year~~eight year period that began in fiscal 2019 with the first payment. The table below provides the expected timing of these future cash outflows, in accordance with the following installment schedule for the remaining ~~four~~three years (in millions):


Remaining 2023		$	5.7
2024		10.6
Remaining 2024
2025	2025	14.1
2026	2026	17.3
Total	Total	$	47.7

Cash Flows. The following table provides a summary of cash flows (in millions):

Three Months Ended
December 31, 2022 January 1, 2022
Cash used in operating activities $ (48.8) $ (89.0)
Cash used in investing activities (21.6) (33.4)
Cash provided by financing activities 39.4 70.0


	Three Months Ended
	December 30, 2023		December 31, 2022
Cash flows used in operating activities	$	(3.0)	$	(48.8)
Cash flows used in investing activities	(28.6)		(21.6)
Cash flows provided by financing activities	5.8		39.4
Effect of exchange rate changes on cash and cash equivalents	1.6		3.4
Net decrease in cash and cash equivalents and restricted cash	$	(24.2)	$	(27.6)

Table of Contents

Operating Activities. Cash flows used in operating activities were ~~$48.8~~$3.0 million for the three months ended December ~~31, 2022,~~30, 2023, as compared to cash flows used in operating activities of ~~$89.0~~$48.8 million for the three months ended ~~January 1,~~December 31, 2022. The ~~change~~decrease was primarily due to cash flow improvements (reductions) of:

•$~~18.8~~(13.0) million ~~increase~~decrease in net income.

•$183.0 million in inventory cash flows driven by inventory levels increasing at a slower rate in the first quarter of fiscal 2023 as compared to the first quarter of fiscal 2022. In the first quarter of fiscal 2023, inventory levels have primarily increased to support the ramp of customer programs, as well as supply chain constraints have led to inflation in some of the components we acquire, increasing inventory.

•~~$80.7 million in accounts receivable cash flows driven by timing of shipments, mix of customer payment terms and increased factoring of receivables.~~

•~~$9.8 million in contract assets cash flows driven by increases in advance payments received from customers who recognize revenue over time.~~

•~~$(128.9)~~58.7 million in accounts payables cash flows primarily driven by the timing of materials procurement and payments to suppliers.

•$~~(88.0)~~26.4 million in ~~other current and non-current liabilities~~inventory cash flows driven by ~~a release of advance payments to customers as we sold products that contained inflated component prices.~~

•~~$(33.6) million in customer deposit cash flows driven by deposits~~inventory levels increasing at a slower rate in the ~~first quarter of fiscal~~three months ended December 30, 2023 as compared to the ~~first quarter of fiscal~~three months ended December 31, 2022 ~~consistent with~~due to fewer program ramps requiring upfront inventory ~~cash flows. Deposit increases in both periods were primarily to cover certain inventory balances.~~procurement.

•$(28.2) million in advanced payments from customers cash flows driven by a larger decrease in advanced payments in the three months ended December 30, 2023 compared to the three months ended December 31, 2022.

•$(9.0) million in contract assets cash flows, driven by decreases in advanced payments received from customers who recognize revenue over time.

The following table provides a summary of cash cycle days for the periods indicated (in days):
Three Months Ended
December 31,
2022 January 1, 2022
Days in accounts receivable 61 66
Days in contract assets 10 12
Days in inventory 151 145
Days in accounts payable (69) (87)
Days in cash deposits (47) (33)
Annualized cash cycle 106 103



	Three Months Ended
	December 30, 2023	December 31, 2022
Days in accounts receivable	61	61
Days in contract assets	12	10
Days in inventory	161	151
Days in accounts payable	(66)	(69)
Days in advanced payments (1)	(73)	(70)
Annualized cash cycle	95	83

(1) Includes a reclassification in the presentation of advanced payments from customers reflected in prior period amounts.As of December 31, 2022, the impact of this reclassification was an increase in the Company's days in advanced payments and a reduction in annualized cash cycle by 23 days.

We calculate days in accounts receivable and contract assets as each balance sheet item for the respective quarter divided by annualized sales for the respective quarter by day. We calculate days in inventory, accounts payable and ~~cash deposits~~advanced payments as each balance sheet line item for the respective quarter divided by annualized cost of sales for the respective quarter by day. We calculate annualized cash cycle as the sum of days in accounts receivable, days in contract assets and days in inventory, less days in accounts payable and days in ~~cash deposits.~~advanced payments.

As of December ~~31, 2022,~~30, 2023, annualized cash cycle days increased ~~three~~twelve days compared to ~~January 1,~~December 31, 2022 due to the following:

Days in accounts receivable for the three months ended December ~~31, 2022 decreased five days~~30, 2023 remained flat compared to the three months ended ~~January 1,~~December 31, 2022. ~~The decrease is primarily attributable to an increase in factored receivables.~~

Days in contract assets for the three months ended December ~~31, 2022 decreased~~30, 2023 increased two days compared to the three months ended ~~January 1,~~December 31, 2022. The ~~decrease~~increase is primarily attributable to ~~increased net sales and an increase~~a decrease in ~~advance~~advanced payments ~~received~~ from customers with arrangements requiring revenue to be recognized over time as products are produced.

Days in inventory for the three months ended December ~~31, 2022~~30, 2023 increased ~~six~~ten days compared to the three months ended ~~January 1,~~December 31, 2022. The increase is primarily ~~attributable to increased inventory levels to support the ramp of customer programs. Inventory levels also increased~~ due to ~~customer demand volatility as well as supply chain constraints which have led~~lower sales in the three months ended December 30, 2023 compared to ~~inflation in some of~~ the ~~components we acquire.~~prior year, partially offset by lower inventory.

Days in accounts payable for the three months ended December ~~31, 2022~~30, 2023 decreased ~~eighteen~~three days compared to the three months ended ~~January 1,~~December 31, 2022. The decrease is primarily attributable to timing of materials procurement and payments to ~~suppliers as well as~~suppliers.

Days in advanced payments for the three months ended December 30, 2023 increased ~~net sales.~~three days compared to the three months ended December 31, 2022. The increase was primarily attributable to lower sales in the three months ended December 30, 2023 compared to the prior year, partially offset by a decrease in advanced payments received from customers in line with lower inventory balances.

Table of Contents

Days in cash deposits for the three months ended December 31, 2022 increased fourteen days compared to the three months ended January 1, 2022. The increase was primarily attributable to significant deposits received from customers to cover certain increasing inventory balances.

Free Cash Flow. We define free cash flow ("FCF"), a non-GAAP financial measure, as cash flow generated or used in operations less capital expenditures. FCF was $(31.7) million for the three months ended December 30, 2023 compared to $(71.9) million for the three months ended December 31, 2022, ~~compared to $(122.2) million for the three months ended January 1, 2022,~~ an improvement of ~~$50.3~~$40.2 million. The improvement in FCF was primarily due to ~~less of a~~lower working capital ~~investment~~investments in inventory to support our customers ~~in the first quarter~~and increased accounts payable due to timing of ~~fiscal 2023 as compared to the first quarter of fiscal 2022.~~payments.

Non-GAAP financial measures, including FCF, are used for internal management assessments because such measures provide additional insight to investors into ongoing financial performance. In particular, we provide FCF because we believe it offers insight into the metrics that are driving management decisions. We view FCF as an important financial metric as it demonstrates our ability to generate cash and can allow us to pursue opportunities that enhance shareholder value. FCF is a non-GAAP financial measure that should be considered in addition to, not as a substitute for, measures of our financial performance prepared in accordance with ~~U.S.~~ GAAP.

A reconciliation of FCF to our financial statements that were prepared using ~~U.S.~~ GAAP as follows (in millions):


			Three Months Ended
			December 31, 2022		January 1, 2022
Cash flows used in operating activities			$	(48.8)	$	(89.0)
		Three Months Ended						Three Months Ended
		December 30, 2023					December 30, 2023		December 31, 2022
Cash flows used in by operating activities
Payments for property, plant and equipment	Payments for property, plant and equipment		(23.1)		(33.2)
Free cash flow	Free cash flow		$	(71.9)	$	(122.2)

Investing Activities. Cash flows used in investing activities were $28.6 million for the three months ended December 30, 2023 compared to $21.6 million for the three months ended December 31, ~~2022 compared to $33.4 million for the three months ended January 1,~~ 2022. The ~~decrease~~increase in cash used in investing activities was due to a ~~$10.2~~$5.6 million ~~decrease~~increase in capital ~~expenditures, as the manufacturing footprint expansion in Bangkok, Thailand has been substantially completed.~~expenditures.

We estimate capital expenditures for fiscal ~~2023~~2024 will be approximately ~~$110.0~~$100.0 million to ~~$130.0~~$120.0 million to support new program ramps and replace older equipment. ~~This estimate does not contemplate any site expansions.~~

Financing Activities. Cash flows provided by financing activities were $5.8 million for the three months ended December 30, 2023 compared to cash flows provided by financing activities of $39.4 million for the three months ended December 31, ~~2022 compared to cash flows provided by financing activities of $70.0 million for the three months ended January 1,~~ 2022. The decrease was primarily attributable to ~~lower~~net borrowings on the credit facility infor the ~~first quarter~~three months ended December 30, 2023 of ~~fiscal 2023~~$10.0 million compared to net borrowings on the credit facility for the three months ended December 31, 2022 of $57.0 million, as ~~compared to the first quarter of fiscal 2022 of $85.0 million.~~

~~On August 11, 2021, the Board of Directors approved~~well as a ~~share repurchase program under which we were authorized to repurchase up to $50.0~~$11.5 million reduction in repurchases of our common stock (the "2022 Program"). The 2022 Program commenced upon completion of the 2021 Program and was completed in fiscal 2022. During the three months ended January 1, 2022, we repurchased 110,440 shares under this program for $10.2 million at an average price of $91.74 per share.stock.

On August 18, 2022, the Board of Directors approved a share repurchase program under which we are authorized to repurchase up to $50.0 million of ~~our~~its common stock (the "2023 Program"). The 2023 Program became effective immediately and has no expiration. During the three months ended December 30, 2023 we purchased no shares under this program. During the three months ended December 31, 2022, we ~~repurchased~~purchased 115,723 shares under this program for $11.5 million at an average price of $99.12 per share. As of December ~~31, 2022, $35.0~~30, 2023, $5.7 million of authority remained under the 2023 Program.

All shares repurchased under the aforementioned ~~programs~~program were recorded as treasury stock.

On January 16, 2024, we announced an additional $50.0 million in share repurchase authority (the "2024 Program") that authorizes us to repurchase our common stock. There is now a total of $55.7 million in repurchase authority under the combined 2023 and 2024 Programs. The 2024 Program will commence upon completion of the 2023 Program.

We have Master Accounts Receivable Purchase Agreements with MUFG Bank, New York Branch (formerly known as The Bank of Tokyo-Mitsubishi UFJ, Ltd.) (the "MUFG RPA"), HSBC Bank (China) Company Limited, Xiamen branch (the "HSBC RPA") and other unaffiliated financial institutions, under which we may elect to sell receivables, at a discount. These facilities are uncommitted facilities. The maximum facility amount under the MUFG RPA as of December ~~31, 2022 was~~30, 2023 is $340.0 million. The maximum facility amount under the HSBC RPA as of December ~~31, 2022 was $60.0~~30, 2023 is $70.0 million. The MUFG RPA will be automatically extended each year unless any party gives no less than 10 days prior notice that the agreement should not be extended. The terms of the HSBC RPA are generally consistent with the terms of the MUFG RPA previously discussed.

~~Table of Contents~~

We sold ~~$185.6~~$223.6 million and ~~$148.0~~$185.6 million of trade accounts receivable under these programs ~~or their predecessors,~~ during the three months ended December ~~31, 2022~~30, 2023 and ~~January 1,~~December 31, 2022, respectively, in exchange for cash proceeds of ~~$183.6~~$221.0 million and ~~$147.5~~$183.6 million, respectively. As of December 30, 2023 and December 31, 2022, ~~and January 1, 2022, $196.8~~$226.9 million and ~~$151.0~~$196.8 million, respectively, of accounts receivables sold under trade accounts receivable programs and subject to servicing by us remained outstanding and had not yet been ~~collected.~~collected by MUFG Bank or HSBC Bank.

Table of Contents

In all cases, the sale discount was recorded within "Miscellaneous, net" in the Condensed Consolidated Statements of Comprehensive Income in the period of the sale. For further information regarding the receivable sale programs, see Note 13, "Trade Accounts Receivable Sale Programs," in Notes to Condensed Consolidated Financial Statements.

Based on current expectations, we believe that our projected cash flows provided by operations, available cash and cash equivalents, ~~our leasing capabilities and~~ potential borrowings under the Credit Facility and our ~~5-year senior unsecured revolving credit facility (referred to as the "Credit Facility"), including our ability to expand our revolving commitment,~~leasing capabilities should be sufficient to meet our working capital and fixed capital requirements, as well as execution upon our share repurchase authorizations as management deems appropriate, for the next twelve months. We believe our balance sheet is positioned to support the potential future challenges presented by ~~macro-economic~~macroeconomic factors including increased working capital requirements associated with longer lead-times for components, increased component and labor costs, and operating inefficiencies due to supply chain constraints. As of the end of the first quarter of fiscal ~~2023,~~2024, cash and cash equivalents and restricted cash were ~~$247.9~~$232 million, while debt, finance lease ~~obligations~~ and other financing obligations were ~~$516.3~~$443 million. If our future financing needs increase, ~~including to support additional capital expenditures or investments in the growth of our business,~~ then we may need to arrange additional debt or equity financing. Accordingly, we evaluate and consider from time to time various financing alternatives to supplement our financial resources. However, we cannot be assured that we will be able to make any such arrangements on acceptable terms or at all.

~~Table of Contents~~

DISCLOSURE ABOUT CRITICAL ACCOUNTING ESTIMATES

Our critical accounting policies are disclosed in our ~~2022~~2023 Annual Report on Form 10-K. During the first quarter of fiscal ~~2023,~~2024, there were no material changes.

NEW ACCOUNTING PRONOUNCEMENTS

See Note 1, ~~"Basis of Presentation,~~"Recently Adopted Accounting Pronouncements" and "Recently Issued Accounting Pronouncements Not Yet Adopted," in Notes to Condensed Consolidated Financial Statements regarding recent accounting pronouncements.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There were no material changes in our exposure to market risk from changes in foreign exchange and interest rates from those disclosed in our ~~2022~~2023 Annual Report on Form 10-K.

Foreign Currency Risk

Our international operations create potential foreign exchange risk. Our policy is to selectively hedge our foreign currency denominated transactions in a manner that partially offsets the effects of changes in foreign currency exchange rates. We typically use foreign currency contracts to hedge only those currency exposures associated with certain assets and liabilities denominated in non-functional currencies. Corresponding gains and losses on the underlying transaction generally offset the gains and losses on these foreign currency hedges. We cannot predict changes in currency rates, nor the degree to which we will be able to manage the impacts of currency exchange rate changes. Such changes could have a material effect on our business, results of operations and financial condition.

Our percentages of transactions denominated in currencies other than the U.S. dollar for the indicated periods were as follows:

Three Months Ended

December 31, 2022

January 1, 2022

December 30, 2023

December 31, 2022

Net Sales

10%

Net Sales

10%

Total Costs

15%

18%

Total Costs

18%

15%

We have evaluated the potential foreign currency exchange rate risk on transactions denominated in currencies other than the U.S. dollar for the periods presented above. Based on our overall currency exposure, as of December ~~31, 2022,~~30, 2023, a 10.0% change in the value of the U.S. dollar relative to our other transactional currencies would not have a material effect on our financial position, results of operations, or cash flows.

Table of Contents

Interest Rate Risk

We have financial instruments, including cash equivalents and debt, which are sensitive to changes in interest rates. The primary objective of our investment activities is to preserve principal, while maximizing yields without significantly increasing market risk. To achieve this, we limit the amount of principal exposure to any one issuer.

As of December ~~31, 2022, our only material~~30, 2023, we were exposed to interest rate risk ~~was~~ associated with our Credit Facility. Borrowings under the Credit Facility bear interest, at the Company's option, at (a)(1) for borrowings denominated in U.S. dollars, the Term Secured Overnight Financing Rate ("SOFR"), (2) for borrowings denominated in pounds sterling, the Daily Simple Risk-Free Rate, plus, in each case of (a)(1) and (2), 10 basis points, (b) for borrowings denominated in euros, the EURIBOR Rate plus a statutory reserve rate, or (c) an Alternate Base Rate equal to the highest of (i) 100 basis points per annum, (ii) the prime rate last quoted by The Wall Street Journal (or, if not quoted, as otherwise provided in the Credit Facility), (iii) the greater of the federal funds effective rate and the overnight bank funding rate in effect on such day plus, in each case, 50 basis points per annum (or, if neither are available, as otherwise provided in the Credit Facility), and (iv) Term SOFR for a one month interest period on such day plus 110 basis points, plus, in each case of (a), (b), and (c), an applicable interest rate margin based on the Company's then current consolidated total indebtedness (minus certain unrestricted cash and cash equivalents in an amount not to exceed $100 million) to consolidated EBITDA. As of December ~~31, 2022,~~30, 2023, the borrowing rate under the Credit Facility was SOFR plus 1.10%. Borrowings under the 2018 NPA are based on a fixed interest rate, thus mitigating much of our interest rate risk. We were also exposed to interest rate risk on our accounts receivables sales programs. The Master Accounts Receivable Purchase Agreements with MUFG Bank, New York Branch (the "MUFG RPA") is subject to an applicable cost of funds based on an applicable margin defined in the agreement with respect to receivables owed by each approved obligor and the applicable SOFR for a period equal to the discount period applicable to such receivable determined as of two business days prior to the applicable purchase date of such receivable with respect to the currency the receivable is denominated in. Other trade receivable sales programs are subject to similar terms. Based on our overall interest rate exposure, as of December ~~31, 2022,~~30, 2023, a 10.0% change in interest rates would not have a material effect on our financial position, results of operations, or cash flows.

~~Table of Contents~~

ITEM 4. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

The Company maintains disclosure controls and procedures designed to ensure that the information the Company must disclose in its filings with the Securities and Exchange Commission ("SEC") is recorded, processed, summarized and reported on a timely basis. The Company’s Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO") have reviewed and evaluated, with the participation of the Company’s management, the Company’s disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act") as of the end of the period covered by this report. Based on such evaluation, the CEO and CFO have concluded that, as of the Evaluation Date, the Company’s disclosure controls and procedures are effective, at the reasonable assurance level, (a) in recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by the Company in the reports the Company files or submits under the Exchange Act, and (b) in assuring that information is accumulated and communicated to the Company’s management, including the CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

During the first quarter of fiscal ~~2023,~~2024, there have been no changes in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

ITEM 5. OTHER INFORMATION

During the quarter ended December 30, 2023, none of our directors or Section 16 officers adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement" (as each term is defined in Item 408(a) of Regulation S-K).

Table of Contents

PART II. OTHER INFORMATION

ITEM 1A. ~~Risk Factors~~RISK FACTORS

In addition to the risks and uncertainties discussed herein, particularly those discussed in the “Safe Harbor” Cautionary Statement and "Management’s Discussion and Analysis of Financial Condition and Results of Operations" in Part I, Item 2, see the risk factors set forth in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended ~~October 1, 2022~~September 30, 2023 that have had no material changes.

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds

~~The following table provides the specified information about the repurchases of shares by us during the three months ended December 31, 2022:~~

Period Total number of shares purchased Average price paid per share Total number of shares purchased as part of publicly announced plans or programs Maximum approximate dollar value of shares that may yet be purchased under the plans or programs (1)
October 2, 2022 -
October 29, 2022 47,769 $ 91.16 47,769 $ 42,165,377
October 30, 2022 -
November 26, 2022 30,306 102.60 30,306 39,055,994
November 27, 2022 -
December 31, 2022 37,648 106.41 37,648 35,049,821
115,723 $ 99.12 115,723

~~(1)~~ On August 18, 2022, the Board of Directors approved a ~~new~~ share repurchase program ~~that authorizes~~under which the Company is authorized to repurchase up to $50.0 million of its common stock (the "2023 Program"). The 2023 Program became effective immediately and has no expiration. There were no shares purchased during the three months ended December 30, 2023. The ~~table above reflects the~~ maximum dollar ~~amount remaining~~value of shares that was available ~~for purchase~~to be purchased under the ~~2023 Program~~program as of December ~~31, 2022.~~30, 2023 was $5.7 million.

On January 16, 2024, we announced an additional $50.0 million in share repurchase authority (the "2024 Program") that authorizes us to repurchase our common stock. The 2024 Program will commence upon completion of the 2023 Program.

~~Table of Contents~~

ITEM 6. EXHIBITS

The list of exhibits is included below.



Exhibit No.						Exhibit
~~10.1~~						~~Form of Performance Stock Unit Agreement (Economic Return)~~
~~10.2~~						~~Form of Performance Stock Unit Agreement (Total Shareholder Return)~~
31.1						Certification of Chief Executive Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002.
31.2						Certification of Chief Financial Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002.
32.1						Certification of the CEO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2						Certification of the CFO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
99.1						Reconciliation of ROIC to GAAP and Economic Return Financial Statements.
101						The following materials from Plexus Corp.’s Quarterly Report on Form 10-Q for the fiscal quarter ended December ~~31, 2022,~~30, 2023, formatted in Inline Extensible Business Reporting Language ("XBRL"): (i) the Condensed Consolidated Statements of Comprehensive Income, (ii) the Condensed Consolidated Balance Sheets, (iii) the Condensed Consolidated Statements of Shareholders’ Equity, (iv) the Condensed Consolidated Statements of Cash Flows, and (v) Notes to Condensed Consolidated Financial Statements.
101.INS						Inline XBRL Instance Document (the instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document).
101.SCH						Inline XBRL Taxonomy Extension Schema Document.
101.CAL						Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.LAB						Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE						Inline XBRL Taxonomy Extension Presentation Linkbase Document.
101.DEF						Inline XBRL Taxonomy Extension Definition Linkbase Document.
104						The cover page from the Company’s Quarterly Report on Form 10-Q for the fiscal first quarter ended December ~~31, 2022,~~30, 2023, formatted in Inline XBRL and contained in Exhibit 101.

2928

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Plexus Corp.

Registrant

Date:

February ~~3, 2023~~2, 2024

/s/ Todd P. Kelsey

Todd P. Kelsey

Chief Executive Officer

Date:

February ~~3, 2023~~2, 2024

/s/ Patrick J. Jermain

Patrick J. Jermain

Executive Vice President and Chief Financial Officer

3029


	Fixed Asset and Operating ROU Asset Impairment		Employee Termination and Severance Costs		Total
Accrual balance, as of October 2, 2021	$	—	$	71	$	71
Restructuring and impairment costs	255		1,766		2,021
Amounts utilized	(255)		(75)		(330)
Accrual balance, as of January 1, 2022	$	—	$	1,762	$	1,762


Period	Total number of shares purchased	Average price paid per share		Total number of shares purchased as part of publicly announced plans or programs	Maximum approximate dollar value of shares that may yet be purchased under the plans or programs (1)
October 2, 2022 - October 29, 2022	47,769	$	91.16	47,769	$	42,165,377
October 30, 2022 - November 26, 2022	30,306	102.60		30,306	39,055,994
November 27, 2022 - December 31, 2022	37,648	106.41		37,648	35,049,821
	115,723	$	99.12	115,723